C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation

Area of Science:

• Biochemistry
• Immunology
• Cardiology

Background:

• Cardiovascular disease (CVD) is a major global health issue, with atherosclerosis as its primary driver.
• Atherosclerosis involves chronic inflammation, with C-reactive protein (CRP) playing a significant role.
• CRP is synthesized mainly in the liver in response to inflammatory cytokines like IL-6, IL-1β, and TNF.

Purpose of the Study:

• To explore the multifaceted role of C-reactive protein (CRP) in the pathophysiology of atherosclerosis.
• To investigate the distinct functions of pentameric and monomeric CRP forms in disease progression.
• To evaluate the utility of high-sensitivity CRP (hs-CRP) measurement for cardiovascular risk assessment.

Main Methods:

• Review of existing literature on CRP's inflammatory mechanisms in atherosclerosis.
• Analysis of studies investigating CRP's effects on vascular cells, complement system, and thrombosis.
• Examination of epidemiological data correlating CRP levels with cardiovascular risk.

Main Results:

• CRP activates complement, induces apoptosis, promotes vascular cell activation, monocyte recruitment, lipid accumulation, and thrombosis.
• CRP exists in pentameric and monomeric forms, with distinct tissue interactions and biological effects.
• Elevated serum CRP levels are epidemiologically associated with increased cardiovascular risk.

Conclusions:

• CRP is a key inflammatory mediator in atherosclerosis, influencing multiple pathogenic pathways.
• The different forms of CRP exert distinct effects, contributing to disease complexity.
• Serum hs-CRP measurement is a valuable tool for assessing an individual's cardiovascular risk.